Exploring the Prognostic Features of Hepatocellular Carcinoma via Text Mining and Data Analysis
- Authors: Yang Z.H.1, Wang S.X.2
- 
							Affiliations: 
							- School of Criminal Law, East China University of Political Science and Law
- Department of Transfusion, Minhang Hospital, Fudan University
 
- Issue: Vol 57, No 3 (2023)
- Pages: 537-538
- Section: БИОИНФОРМАТИКА
- URL: https://cardiosomatics.ru/0026-8984/article/view/655426
- DOI: https://doi.org/10.31857/S0026898423030187
- EDN: https://elibrary.ru/CHYJBX
- ID: 655426
Cite item
Abstract
Transcatheter arterial chemoembolization is one of the interventional treatments for hepatocellular carcinoma (HCC). This treatment is generally used for patients with intermediate to advanced hepatocellular carcinoma, and identifying the role of HCC-related genes can help improve the efficiency of transcatheter arterial chemoembolization. To investigate the role of HCC-related genes and to provide valid evidence for transcatheter arterial chemoembolization treatment, we performed a comprehensive bioinformatics analysis. Through text mining (“hepatocellular carcinoma”) and microarray data analysis (GSE104580), we obtained a standard gene set, which was followed by gene ontology and Kyoto Gene and Genome Encyclopedia analysis. The significant 8 genes clustered in protein-protein interactions network were chosen to be used in the follow-up analysis. Through survival analysis low expression of the key genes were found to be strongly associated with survival in HCC patients in this study. The correlation between the expression of the key genes and tumor immune infiltration was assessed by Pearson correlation analysis. As a result, 15 drugs targeting seven of the eight genes have been identified, and therefore can be considered as potential components for transcatheter arterial chemoembolization treatment of HCC.
About the authors
Z. H. Yang
School of Criminal Law, East China University of Political Science and Law
														Email: 2021110083@ecupl.edu.cn
				                					                																			                												                								China, 200042, Shanghai						
S. X. Wang
Department of Transfusion, Minhang Hospital, Fudan University
							Author for correspondence.
							Email: 2021110083@ecupl.edu.cn
				                					                																			                												                								China, 201199, Shanghai						
References
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
									

 
  
  
  Email this article
			Email this article 
 Open Access
		                                Open Access Access granted
						Access granted Subscription or Fee Access
		                                							Subscription or Fee Access
		                                					